0001807094-20-000003.txt : 20200330 0001807094-20-000003.hdr.sgml : 20200330 20200330160701 ACCESSION NUMBER: 0001807094-20-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200330 DATE AS OF CHANGE: 20200330 EFFECTIVENESS DATE: 20200330 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CytoDyn Inc. CENTRAL INDEX KEY: 0001175680 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 753056237 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-363932 FILM NUMBER: 20757038 BUSINESS ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 BUSINESS PHONE: 360-980-8524 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 FORMER COMPANY: FORMER CONFORMED NAME: CYTODYN INC DATE OF NAME CHANGE: 20031114 FORMER COMPANY: FORMER CONFORMED NAME: REXRAY CORP DATE OF NAME CHANGE: 20020617 D 1 primary_doc.xml X0708 D LIVE 0001175680 CytoDyn Inc. 1111 MAIN STREET, SUITE 660 VANCOUVER WA WASHINGTON 98660 360-980-8524 DELAWARE RexRay Corporation CYTODYN INC REXRAY CORP Corporation true Nader Z Pourhassan 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Executive Officer Director Craig Eastwood 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Executive Officer Jordan G Naydenov 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director Alan P Timmins 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director Scott A Kelly 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director David F Welch 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director Arian Colachis 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Executive Officer Biotechnology Decline to Disclose 06b false 2020-03-13 false true true true false 0 1157625 882000 275625 false 1 0 0 0 Some of the proceeds may be used for general working capital purposes which may include the payment of salaries and other fees to those listed in Item 3. false CytoDyn Inc. /s/ Craig Eastwood Craig Eastwood Chief Financial Officer 2020-03-30